Literature DB >> 6871167

Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identification of residue 63 as beta-hydroxyaspartic acid.

B A McMullen, K Fujikawa, W Kisiel, T Sasagawa, W N Howald, E Y Kwa, B Weinstein.   

Abstract

The complete amino acid sequence of the light chain of human blood coagulation factor X has been determined by automated Edman degradation of peptides isolated from chemical and enzymatic digests of the carboxymethylated light chain. The protein consists of 139 amino acid residues, which include 11 residues of gamma-carboxyglutamic acid. The first 100 residues of the human factor X light chain exhibit approximately 80% homology when compared to the amino-terminal sequence of bovine factor X light chain. This homology decreases to approximately 50% in the remaining 39 residues of the carboxyl-terminal region of the protein. Proton nuclear magnetic resonance spectroscopy and mass spectrometry analyses of isolated residue 63 identified this residue as L-erythro-beta-hydroxyaspartic acid, a hitherto unrecognized amino acid in proteins. Evidence is also presented for the presence of this residue in the corresponding regions of the light chains of bovine factor X and bovine protein C. The biological function of beta-hydroxyaspartic acid in these proteins is unknown.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871167     DOI: 10.1021/bi00281a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

Review 1.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

2.  Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa.

Authors:  Veena S Rao; Jeremiah S Joseph; R Manjunatha Kini
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

3.  Sequence of the cDNA encoding the laminin B1 chain reveals a multidomain protein containing cysteine-rich repeats.

Authors:  M Sasaki; S Kato; K Kohno; G R Martin; Y Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

4.  Intrinsic versus extrinsic coagulation. Kinetic considerations.

Authors:  B J Warn-Cramer; S P Bajaj
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

5.  Complete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1r.

Authors:  G J Arlaud; A C Willis; J Gagnon
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

6.  Human Protein Z.

Authors:  G J Broze; J P Miletich
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Beta-methylthio-aspartic acid: identification of a novel posttranslational modification in ribosomal protein S12 from Escherichia coli.

Authors:  J A Kowalak; K A Walsh
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

8.  Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion.

Authors:  H H Watzke; A Wallmark; N Hamaguchi; P Giardina; D W Stafford; K A High
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

9.  Aspartyl beta-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IX.

Authors:  R S Gronke; W J VanDusen; V M Garsky; J W Jacobs; M K Sardana; A M Stern; P A Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Characterization of a cDNA coding for human factor X.

Authors:  S P Leytus; D W Chung; W Kisiel; K Kurachi; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.